VivoSeq
Other

Pregnant Women and Their Offspring

0

Pipeline Programs↗

3

Active Trials↗

4

Companies Involved↗

Pregnant Women and Their Offspring is an early-stage landscape with 0 programs across 4 companies. The most active players are Novartis, Phathom Pharmaceuticals, Inc., Bristol-Myers Squibb.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

PreclinicalP

Phathom Pharmaceuticals, Inc.

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Recruiting2 · 40%
Completed2 · 40%
Active, not recruiting1 · 20%

Clinical Trials

Trial Activity

A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Recruiting·PPhathom Pharmaceuticals, Inc.·N/A·NCT06660342·728 enrolled
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
Completed·Novartis logoNovartis·Phase 2·NCT01412801·270 enrolled
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
Completed·Novartis logoNovartis·Phase 2·NCT01446289·86 enrolled
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Active, not recruiting·Bristol-Myers Squibb logoBristol-Myers Squibb·N/A·NCT06710470·833 enrolled
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Recruiting·Pfizer logoPfizer·N/A·NCT05721937·400 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)